Form 4 Tracker
Joshua Bleharski

Chief Financial Officer; Director · 2 filings · Latest: Jul 23, 2026

IDEAYA Biosciences, Inc.
Scribe Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
Joshua Bleharski — Insider Trading Activity | LevelFields AI